This is a third-party organization specializing in genetic testing of mental illness drugs, which has national qualification certification and is well-known in China. Their project to improve the ability of precision medical services for mental illness or to support the development of Shanghai's service industry in 2020 was officially affirmed.
In today's society, the incidence of mental illness such as depression is still relatively high. In addition to genetic factors, high-pressure environment is also a major factor leading to mental illness. No matter what causes the disease, individualized treatment should be realized to achieve the best therapeutic effect and alleviate the pain of patients. If the traditional treatment scheme is still adopted, not only can it not be completely cured, but it will even aggravate the condition.
This kind of genetic testing can clarify everyone's information about drug reactions and adverse drug reactions, and then assist doctors to formulate medication plans in clinic, thus improving the effectiveness and safety of psychotropic drugs and helping patients achieve accurate treatment.
In many medical conferences in China, especially those related to mental illness, the value of pharmacogenomics will be mentioned and affirmed when precise treatment is mentioned. For example, at the 26th International Forum on Psychosomatic Medicine held by Chinese Medical Association on June 65438+1October 65438+July 2020, the positive role of genetic testing in individualized treatment was highly recognized by the participating experts.